Literature DB >> 20376721

Applied field research for comprehensive helminth infection control.

Peter T Soboslay1, Richard G Gantin, Méba Banla, Potochoziou K Karabou, Abram Agossou, John K Douti, Gnansa Djassoa, Christoph Heuschkel, Hartwig Schulz-Key, David M Hamm, Peter Stingl.   

Abstract

The Institute for Tropical Medicine at University of Tübingen has established 30 years ago in Togo a Research Centre and Onchocerciasis Reference Laboratory (ORL). Onchocerca volvulus infection control and of other neglected tropical diseases has been the focus of activities, and those were performed together with the National Institute of Hygiene in Togo, the Medical Faculty at University of Lomé, national disease control programs and district and regional hospitals. The ORL contributed significantly to the assessment of ivermectin as the prime choice for onchocerciasis treatment, and 24 years of repeated annual treatment with ivermectin has progressively reduced disease prevalence and notably the level of ocular and dermal manifestations of onchocerciasis in the endemic population. The ORL has shown that large parts of the rural population in Togo is concurrently infected with intestinal and intravascular protozoan and helminth parasites, notably school children. The application of repeated treatments with albendazole and praziquantel against Schistosoma spp. and instestinal helminthes for several years has reduced infection intensities by more than 80%. Longitudinal investigations of the cellular immune responses in adults and children have found that parasite co-infections will generate prominent pro-inflammatory responses, and a single or few interventions will not suffice to eliminate co-infections and not establish an appropriately balanced immunity.

Entities:  

Mesh:

Year:  2010        PMID: 20376721     DOI: 10.1007/s00508-010-1332-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  17 in total

Review 1.  Onchocercal eye disease and the impact of Mectizan treatment.

Authors:  A Abiose
Journal:  Ann Trop Med Parasitol       Date:  1998-04

2.  Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.

Authors:  C S Mai; D M Hamm; M Banla; A Agossou; H Schulz-Key; C Heuschkel; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

3.  Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.

Authors:  P T Soboslay; C G Lüder; W H Hoffmann; I Michaelis; G Helling; C Heuschkel; C M Dreweck; C H Blanke; S Pritze; M Banla
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

4.  Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus.

Authors:  Achim Hoerauf; Sabine Specht; Yeboah Marfo-Debrekyei; Marcelle Büttner; Alexander Yaw Debrah; Sabine Mand; Linda Batsa; Norbert Brattig; Peter Konadu; Claudio Bandi; Rolf Fimmers; Ohene Adjei; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2008-10-11       Impact factor: 2.289

5.  Cattle protected from onchocerciasis by ivermectin are highly susceptible to infection after drug withdrawal.

Authors:  L M Njongmeta; C K Nfon; J Gilbert; B L Makepeace; V N Tanya; A J Trees
Journal:  Int J Parasitol       Date:  2004-08       Impact factor: 3.981

6.  An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.

Authors:  K Awadzi; D A Boakye; G Edwards; N O Opoku; S K Attah; M Y Osei-Atweneboana; J K Lazdins-Helds; A E Ardrey; E T Addy; B T Quartey; K Ahmed; B A Boatin; E W Soumbey-Alley
Journal:  Ann Trop Med Parasitol       Date:  2004-04

7.  Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus.

Authors:  K Y Dadzie; J Remme; G De Sole
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Mar-Apr       Impact factor: 2.184

8.  Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.

Authors:  P T Soboslay; C M Dreweck; W H Hoffmann; C G Lüder; C Heuschkel; H Görgen; M Banla; H Schulz-Key
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

9.  Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden.

Authors:  Peter J Hotez; Aruna Kamath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25

10.  Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.

Authors:  Lamine Diawara; Mamadou O Traoré; Alioune Badji; Yiriba Bissan; Konimba Doumbia; Soula F Goita; Lassana Konaté; Kalifa Mounkoro; Moussa D Sarr; Amadou F Seck; Laurent Toé; Seyni Tourée; Jan H F Remme
Journal:  PLoS Negl Trop Dis       Date:  2009-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.